Thermo Fisher Scientific (TMO) EBIT Margin (2009 - 2026)

Thermo Fisher Scientific has reported EBIT Margin for 18 years, with the latest figure at 17.4% in Q2 2026.

• EBIT Margin for Q2 2026 came in at 17.4%, up 50.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 17.58% (up 45.0% YoY), and the FY2025 annual result was 17.38%, up 27.0% from the prior year.
• EBIT Margin rose to 17.4% in Q2 2026, from 16.93% in the prior quarter.
• Over five years, EBIT Margin peaked at 23.87% in Q2 2022 and troughed at 14.59% in Q2 2023.
• A 5-year average of 17.25% and a median of 17.15% in 2023 frame the typical range for EBIT Margin.
• The widest annual swing landed in 2023, when EBIT Margin slumped 928 bps; it then jumped 250 bps in 2024.
• A 5-year view of EBIT Margin shows it stood at 16.25% in 2022, then climbed by 5 bps to 17.03% in 2023, then advanced by 4 bps to 17.69% in 2024, then grew by 4 bps to 18.46% in 2025, then dropped by 6 bps to 17.4% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 17.4% in Q2 2026, 16.93% in Q1 2026, and 18.46% in Q4 2025.